Selected Dietary and Supplemental Phytochemicals in Adiposity-Based Chronic Disease: Molecular Mechanisms, Human Evidence, and Translational Gaps
Nutrients · 31.10.2026 · 18 (21) · 3630
DOI: 10.3390/nu18213630 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 31.10.2026. Verfasst von Arguiñe Ivonne Urraza-Robledo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Mezclas Oncológicas, Unidad Médica de Alta Especialidad No. 71, Instituto Mexicano del Seguro Social, Coahuila de Zaragoza 27000, Mexico. Hauptthemen laut MEDLINE: Phytochemicals, Adiposity, Dietary Supplements, Obesity. Die Arbeit nennt 168 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Adiposity-based chronic disease (ABCD) encompasses the health consequences of excess or dysfunctional adipose tissue. Selected phytochemicals have been investigated as potential adjuncts, but experimental pathway activity does not establish clinical benefit. This narrative review examines quercetin, chlorogenic acids, epigallocatechin-3-gallate (EGCG), and berberine, with other interventions providing context. The evidence was supplemented by targeted PubMed searches through 27 October 2026 and appraised according to experimental model, formulation, exposure, clinical relevance, and safety. Published pooled body-weight differences were −0.35 kg (95% confidence interval, −2.03 to 1.33) for quercetin, −1.30 kg (−2.07 to −0.52) for selected green-coffee/chlorogenic-acid interventions, −0.74 kg (−0.97 to −0.51) for green-tea preparations, and −0.88 kg (−1.36 to −0.39) for berberine. These source-specific estimates are not head-to-head comparisons. A small crossover trial of quercetin reported reduced hepatic fat, whereas a six-month berberine trial found no significant benefit for visceral or hepatic fat. Coffee and green-tea findings do not isolate the effects of chlorogenic acid or EGCG. Most mechanistic evidence remains preclinical, and differences in chemical composition, circulating metabolites, administration, and outcome selection limit translation. The human-evidence-based selection also underrepresents less-studied phytochemicals; for the evaluated interventions, sustained adiposity reduction and patient-relevant benefit remain insufficiently established. Their potential role in comprehensive ABCD care requires product-specific assessment of efficacy, exposure, adverse effects, and interactions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centro de Mezclas Oncológicas, Unidad Médica de Alta Especialidad No. 71, Instituto Mexicano del Seguro Social, Coahuila de Zaragoza 27000, Mexico.
- Centro de Investigación Facultad de Medicina UNAM-UABJO, Facultad de Medicina y Cirugía, Universidad Autónoma "Benito Juárez" de Oaxaca, Oaxaca 68020, Mexico.
- Instituto Mexicano del Seguro Social, Hospital General de Zona con Medicina Familiar No. 18, Coahuila de Zaragoza 27220, Mexico.
- Secretaría de Ciencia, Humanidades, Tecnología e Innovación (SECIHTI), Departamento de Farmacología, Facultad de Medicina, Universidad Autónoma de Coahuila, Coahuila de Zaragoza 25000, Mexico.
- Secretaría de Ciencia, Humanidades, Tecnología e Innovación (SECIHTI), Facultad de Medicina y Cirugía, Universidad Autónoma "Benito Juárez" de Oaxaca, Oaxaca 68020, Mexico.
- División de Estudios de Posgrado e Investigación, Tecnológico Nacional de México, Instituto Tecnológico de Oaxaca, Oaxaca 68030, Mexico.
ORCID-Profile: Arguiñe Ivonne Urraza-Robledo, Ibzan Jahzeel Salvador Ibarra, Anahí Jobeth Borrás Enríquez, Eduardo Pérez-Campos, Laura Pérez-Campos Mayoral, Daniel Gómez Hernández, María Del Socorro Pina-Canseco, Hector Alejandro Cabrera-Fuentes, María Teresa Hernández-Huerta
Zitieren
APA
Urraza-Robledo, A. I., Díaz García, E. J., Salvador Ibarra, I. J., Mora Guzmán, Z., Borrás Enríquez, A. J., Pérez-Campos, E., Pérez-Campos Mayoral, L., Gómez Hernández, D., Pina-Canseco, M. D. S., Cabrera-Fuentes, H. A., & Hernández-Huerta, M. T. (2026). Selected Dietary and Supplemental Phytochemicals in Adiposity-Based Chronic Disease: Molecular Mechanisms, Human Evidence, and Translational Gaps. Nutrients, 18(21), 3630. https://doi.org/10.3390/nu18213630
Vancouver
Urraza-Robledo AI, Díaz García EJ, Salvador Ibarra IJ, Mora Guzmán Z, Borrás Enríquez AJ, Pérez-Campos E, et al. Selected Dietary and Supplemental Phytochemicals in Adiposity-Based Chronic Disease: Molecular Mechanisms, Human Evidence, and Translational Gaps. Nutrients. 2026;18(21):3630. doi:10.3390/nu18213630
BibTeX
@article{UrrazaRobledo2026,
author = {Urraza-Robledo, Arguiñe Ivonne and Díaz García, Edmar de Jesús and Salvador Ibarra, Ibzan Jahzeel and Mora Guzmán, Zoila and Borrás Enríquez, Anahí Jobeth and Pérez-Campos, Eduardo and Pérez-Campos Mayoral, Laura and Gómez Hernández, Daniel and Pina-Canseco, María Del Socorro and Cabrera-Fuentes, Hector Alejandro and Hernández-Huerta, María Teresa},
title = {Selected Dietary and Supplemental Phytochemicals in Adiposity-Based Chronic Disease: Molecular Mechanisms, Human Evidence, and Translational Gaps},
journal = {Nutrients},
year = {2026},
volume = {18},
number = {21},
pages = {3630},
doi = {10.3390/nu18213630}
}
EUVIMED